Negar Almassi MPS[/caption]
Dr Brian Chia MPS[/caption]
COPD is significantly underdiagnosed
Associate Professor Debbie Rigby FPS[/caption]
Nicolette Ellis MPS[/caption]
A national education program for pharmacists funded by the Australian Government under the Quality Use of Diagnostics, Therapeutics and Pathology program.[/caption]
Both these disorders can occur separately, but if they co-occur, this is termed COMISA. Approximately 30–50% of people with OSA have comorbid insomnia, and 30–40% of people with chronic insomnia have comorbid OSA.9,12 A recent population-based study reported that 11% of Australian adults report symptoms of COMISA.13
The ‘gold standard’ measure of OSA presence and severity is an overnight sleep study (Table 1).25 The most common single metric to determine OSA presence and severity is the apnoea-hypopnoea index (AHI), representing the average number of airway narrowing and closure events occurring per hour of sleep.24 Identifying the most appropriate management approaches for OSA also requires consideration of lifestyle factors, symptoms and consequences, occupation, chronic conditions, and other sleep conditions. Self-report questionnaires may be used to screen for a high-risk of OSA and identify patients suitable for referral and consideration of overnight sleep study assessment (Table 1).24
Although evidence-based guidelines unanimously recommend avoiding long-term use of hypnotics, they are indicated for a minority of patients that present with severe acute insomnia that is causing significant psychological distress or functional impairment.29 Most people who experience short-term insomnia symptoms (1–2 weeks) can be reassured that sleep will return to ‘normal’ after the underlying precipitant has subsided, without targeted treatment (i.e. hypnotic medicines).29,33 For those who experience persistent insomnia, cognitive behavioural therapy for insomnia (CBTi) is the first-line treatment. Pharmacotherapy may be considered in patients with severe insomnia that is causing significant impairment or distress (e.g. times of acute work/exam stress, bereavement).34
Tailored recommendations for non-CPAP therapies may also be provided to patients with different levels of OSA severity and presenting features.17 For example, weight management advice where indicated, positional devices (in the presence of supine-predominant OSA), mandibular advancement splints (in patients with mild-to-moderate OSA), and upper airway surgery are effective treatments that may be tailored to each individual patient.24
Dr Alexander Sweetman (he/him) PhD
Senior Program Manager, and chair of the psychologist education subcommittee at the Australasian Sleep Association.
Associate Professor Sutapa Mukherjee (she/her) MBBS, FRACP, PhD
Respiratory and sleep physician, Associate Professor of Respiratory and Sleep Medicine at Flinders University and past President of the Australasian Sleep Association.
Professor Garun Hamilton (he/him) MBBS, FRACP, PhD
Respiratory and sleep physician, clinical professor at Monash Health and Monash University and President of the Australasian Sleep Association.
Professor John Turnidge AO[/caption]
Pharmacists have been given a powerful new tool for giving advice to Australia’s diverse communities, after the Department of Social Services substantially expanded access to its Free Interpreting Service.
Until recently, the phone-based service had only been able to be...
An English project looking to reduce medicines wastage across community pharmacy, care homes and general practice has produced savings representing a return of nearly £4.28 on every £1 spent on its development.1
‘Community pharmacy teams are in the unique...
Scenario
A patient, who identifies as an Aboriginal person, presents to the pharmacy for her monthly prescriptions. Her prescriptions are not annotated as ‘CTG - Closing The Gap PBS Co-payment Measure’. She queries why she has to pay for her...
The Northern Territory Government is offering incentives for pharmacists and pharmacy technicians to relocate to fill a skills shortage. But what is pharmacist life like at the Top End?
A list of ‘hard to fill’ occupations has been released, offering...
How can pharmacists get involved in international aid and healthcare service provision overseas?
Working as a pharmacist in overseas development can be stressful – but it is also an incredibly rewarding career path and will change the way you...
With community pharmacies feeling the squeeze, there has never been a more important time to provide continuity of care by building patient loyalty.
Self-serve checkouts, online stores and banking through phone apps: these days there’s often little need to talk...
Leaders from pharmacy, medical and consumer organisations will gather in Canberra on Tuesday to explore how doctors and pharmacists can better cooperate to support patient care and safety.
PSA’s inter-professional collaboration summit was prompted by the Victorian Coroner’s recent report...
The combined measles-mumps-rubella (MMR) vaccine will soon be available from community pharmacies across Victoria, under a new State Government initiative.
In last week’s announcement, Victorian Health Minister Jill Hennessy also lowered the eligible age for pharmacy-administered vaccinations from 18 to...
From wonder drug to scourge. The synthesis of amphetamine has had a profound effect on society as well as attitudes towards drugs.
From its use treating asthma and nasal congestion, to being prescribed for depression, epilepsy, drug and alcohol addiction...
The introduction of direct-acting antivirals therapies for hepatitis C in 2016 has contributed to a 20% decline in deaths attributed to the disease, but a drop in the number of people accessing the cure has public health authorities worried.
This...
